Dr. Farah Brasfield is the Excellence in Cancer Care physician lead for Kaiser Permanente in Southern California (SCPMG). She also serves as chief of SCPMG Hematology and Oncology, chair of the SCPMG Cancer Committee and Multidisciplinary Oncology Subcommittees, co-chair of the KP National Genomic Oncology Program, and co-chair of the SCPMG Molecular Pathology Team. She has practiced breast oncology at SCPMG for 22 years.
Dr. Brasfield completed her premedical studies in biochemistry and biophysics, as well as four years of bench research in immunology and biological therapy at the University of Texas MD Anderson. Her studies were specialized in the development of tests such as fluorescent in situ hybridization and immunotherapy drug trials in cancer and HIV patients. She received her medical degree from Texas A&M Health Sciences Center and completed her residency and fellowship in hematology oncology at the University of Arizona.
Dr. Brasfield is a National Cancer Institute (NCI) investigator and sub-investigator and has presented her research abstracts and publications at both the American Society of Clinical Oncology and European Society of Hematology Oncology.